SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-1
Document Type: S-1
Date Filed: 2026-05-15
Accession Number: 0001213900-26-057939
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390026057939/ea0290954-s1_synergy.htm

Chunk 1 of 16
Word Count: 1435
Character Count: 9637

Document Content:

sale by the Selling Stockholder of the shares of our common stock offered We may also file a prospectus supplement or post-effective amendment to the Registration Statement that may contain material information relating to this offering. The prospectus supplement or post-effective amendment may also add, update or change information contained in this prospectus. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or post-effective amendment, you should rely on the prospectus supplement or post-effective amendment, as applicable. The Registration Statement includes exhibits that provide more detail regarding the matters discussed in this prospectus. You should read this prospectus, any post-effective amendment, and any applicable prospectus supplement and the related exhibits filed with the SEC before making your investment decision. The Registration Statement and the exhibits can be obtained from the SEC, as indicated under the section entitled “Where You Can Find More Information.”

We incorporate by reference
important information into this prospectus. You may obtain the information incorporated by reference without charge by following the instructions
under “Where You Can Find More Information.” You should carefully read this prospectus as well as additional information
described under “Incorporation of Certain Information By Reference” before deciding to invest in our securities.

You should rely only on the
information contained in this prospectus and any applicable prospectus supplement or post-effective amendment. We have not authorized
anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely
on it. The information contained in this prospectus is accurate only as of the date of this prospectus and the information contained in
any prospectus supplement or post-effective amendment is accurate only as of the date of that document. Our business, financial condition,
results of operations and prospects may have changed since those dates. Other than as required under the federal securities laws, we undertake
no obligation to publicly update or revise any information in this prospectus, any prospectus supplement or any post-effective amendment,
whether as a result of new information, future events or otherwise.

This prospectus does not constitute
an offer to sell or the solicitation of an offer to buy any of our securities other than the securities covered hereby, nor does this
prospectus constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction to any person to whom
it is unlawful to make such offer or solicitation in such jurisdiction. Persons who come into possession of this prospectus in jurisdictions
outside the United States are required to inform themselves about, and to observe, any restrictions as to the offering and the distribution
of this prospectus applicable to those jurisdictions.

This prospectus contains summaries
of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete
information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to
herein have been filed, will be filed, or will be incorporated by reference as exhibits to the registration statement of which this prospectus
is a part, and you may obtain copies of those documents as described below under the sections entitled “Where You Can Find More
Information” and “Incorporation of Certain Information by Reference.”

Trademarks

We own or have rights to various
trademarks, service marks and trade names that we use in connection with the operation of our business. This prospectus and the information
incorporated by reference herein may also contain trademarks, service marks and trade names of third parties, which are the property of
their respective owners. Our use or display of third parties’ trademarks, service marks and trade names or products in this prospectus
or information incorporated by reference herein is not intended to, and does not imply a relationship with, or endorsement or sponsorship
by us. Solely for convenience, the trademarks, service marks and trade names referred to in this prospectus or in the information incorporated
by reference herein may appear without the ®, TM or SM symbols, but the omission of such
references is not intended to indicate, in any way, that we will assert, to the fullest extent under applicable law, our rights or the
right of the applicable owner of these trademarks, service marks and trade names.

Market and Industry Data

Unless otherwise indicated,
information contained and incorporated by reference in this prospectus concerning our industry, competitive position and the markets in
which we operate is based on information from independent industry and research organizations, other third-party sources and management
estimates. Management estimates are derived from publicly available information released by independent industry analysts and other third-party sources,
as well as data from our internal research, and are based on assumptions we made upon reviewing such data, and our experience in, and
knowledge of, such industry and markets, which we believe to be reasonable. In addition, projections, assumptions and estimates of the
future performance of the industry in which we operate and our future performance are necessarily subject to uncertainty and risk due
to a variety of factors, including those described in the sections entitled “Risk Factors” and “Cautionary
Note Regarding Forward-Looking Statements” contained or incorporated by reference in this prospectus. These and other
factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by us.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This prospectus and the documents
incorporated by reference into this prospectus include statements that express our opinions, expectations, beliefs, plans, objectives,
assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking
statements.” All statements other than statements of historical facts contained in this prospectus and the documents incorporated
by reference into this prospectus may be forward-looking statements. These forward-looking statements can generally be identified by the
use of forward-looking terminology, including the terms “believes,” “estimates,” “continues,” “anticipates,”
“expects,” “seeks,” “projects,” “intends,” “plans,” “may,” “will,”
“would” or “should” or, in each case, their negative or other variations or comparable terminology. They appear
in a number of places throughout this prospectus and the documents incorporated by reference into this prospectus, and include statements
regarding our intentions, beliefs or current expectations concerning, among other things, our results of operations, financial condition,
liquidity, prospects, growth, strategies, future acquisitions and the industry in which we operate.

By their nature, forward-looking
statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the
future. We believe that these risks and uncertainties include, but are not limited to, those described in the “Risk Factors”
section of this prospectus and under similar headings in the documents incorporated by reference into this prospectus, which include,
but are not limited to, risks related to the following:

●	our ability to compete in our industry, including against competitors
that have significantly greater financial, technical and marketing resources than we do;

●	our ability to respond to customer preferences and successfully
develop new and innovative products in a timely manner and effectively manage the introduction of new or enhanced products;

●	risks related to a loss of, or material cancellation, reduction,
or delay in purchases by, one or more of our largest customers;

●	our outside suppliers and manufacturers failing to supply products
in sufficient quantities and in a timely fashion;

●	our ability to execute on our strategic initiatives (including
acquisitions);

●	our ability to maintain the reputation of our brands;

●	the risks related to consumers’ perception of the safety
and quality of our products as well as similar products distributed by other companies in our industry;

●	the risks related to third parties asserting intellectual property
infringement claims against us;

●	the risks related to our planned expansion into additional international
markets;

●	the risks related to adverse economic conditions;

●	the risks related to catastrophic events;

●	our ability to retain key personnel, manage our business effectively,
and continue to grow;

●	the impact of numerous laws and regulations that apply to the
manufacture and sale of nutritional supplements, and compliance with these laws and regulations, as they currently exist or as modified
in the future, on us and our suppliers;

●	the risks related to product recalls;

●	the risks related to product liability claims and litigation
to prosecute such claims; and

●	the other factors described in “ Risk Factors .”

These factors should not be
construed as exhaustive and should be read with the other cautionary statements in this prospectus and the documents incorporated by reference
into this prospectus.